Global Urea Cycle Disorder Market Share

Statistics for the 2023 & 2024 Global Urea Cycle Disorder market share, created by Mordor Intelligence™ Industry Reports. Global Urea Cycle Disorder share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Urea Cycle Disorder Industry

The market is fragmented and moderately competitive. The strategies such as mergers and acquisitions adopted by major market players will boost the studied market growth. The major players in the market are Bausch Health Companies Inc., Recordati Rare Diseases, Eurocept Pharmaceuticals Holding (Lucane Pharma SA), Acer Therapeutics, Ultragenyx Pharmaceutical, and others.

Urea Cycle Disorder Market Leaders

  1. Bausch Health Companies Inc.

  2. Recordati Rare Diseases

  3. Eurocept Pharmaceuticals Holding (Lucane Pharma SA)

  4. Acer Therapeutics

  5. Ultragenyx Pharmaceutical

*Disclaimer: Major Players sorted in no particular order

mark conc urea.png

Urea Cycle Disorder Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)